Navigation Links
Paloma Pharmaceuticals Presents at the Association for Research in Vision and Ophthalmology 2009 Meeting
Date:5/6/2009

development. Palomid 529 is a first-in-class dual TORC1/TORC2 inhibitor.

About Paloma Pharmaceuticals

Paloma Pharmaceuticals, Inc. is an early stage drug development company focusing on cancer, ocular diseases (macular degeneration, diabetic retinopathy and proliferative vitreoretinopathy), arthritis, fibrotic diseases (pulmonary fibrosis), viral (HIV) and skin diseases (psoriasis and atopic dermatitis). Paloma owns the intellectual property relating to a library of novel, proprietary, small molecule drugs created through an integrated design platform incorporating proprietary, customized and industry standard computational tools that has therapeutic potential for the treatment of the foregoing diseases.

http://www.palomapharma.com

CONTACT: David Sherris, dsherris@palomapharma.com, (617) 407-6314


'/>"/>
SOURCE Paloma Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Poniard Pharmaceuticals Reports First Quarter 2009 Financial Results and Provides a Corporate Update
2. Transcept Pharmaceuticals to Report First Quarter 2009 Results
3. Oramed Pharmaceuticals Announces Launch of Phase 2B Clinical Trials in South Africa of its Oral Insulin Capsule
4. Potentia Pharmaceuticals POT-4 Drug Candidate for Age-Related Macular Degeneration Successfully Completes Phase I Clinical Trial - Prepares for Phase II
5. Poniard Pharmaceuticals to Present New Data from Phase 2 Clinical Trials of Picoplatin in Multiple Tumor Types at the 45th Annual Meeting of the American Society of Clinical Oncology
6. Peregrine Pharmaceuticals Completes Patient Enrollment in its Phase II Trial of Bavituximab Plus Docetaxel in Breast Cancer Patients
7. Raptor Pharmaceuticals Receives Notices of Allowance for Two NeuroTrans(TM) Patent Applications
8. Merz Pharmaceuticals Announces Results of Three Clinical Trials With NT-201 (Botulinum Neurotoxin Type A Free From Complexing Proteins) in Movement Disorder Patients
9. Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 First Quarter Results
10. Affitech-Discovered Anti-PS Antibodies in Development by Peregrine Pharmaceuticals Show Excellent Functionality in Preclinical Studies
11. Ferring Pharmaceuticals Launches Phase IIIB Trial of Degarelix as Intermittent Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... 23, 2014 UBM Medica US today announced ... online community and information resource for neurologists and other ... their patients with neurological disorders . ... population, necessitates greater access to dedicated information for healthcare ... neurological conditions include: , 1 in 6 ...
(Date:7/23/2014)... OSCEOLA, Wis. and MOUNTAIN VIEW, ... Inc. ("Surpass"), a recognized leader in translational preclinical research, ... at www.surpassinc.com ), signaling the transformation of Surpass, ... integrated innovation partner for our customers. This press release ... that two integral hires were added to the Silicon ...
(Date:7/23/2014)... , July 23, 2014 NOT ... DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE ... LAWS OR REGULATIONS OF SUCH JURISDICTION. AbbVie (NYSE: ... results on Friday, July 25, 2014, before the market opens. ... earnings conference call at 8 a.m. Central time (9 a.m. ...
Breaking Medicine Technology:UBM Medica US Launches NeurologyTimes.com 2UBM Medica US Launches NeurologyTimes.com 3SURPASS Launches New Company Logo and Corporate Website, Symbolizing Transformation of Company Culture to Meet the Changing Needs of Clients in the Life Science Community Today. 2SURPASS Launches New Company Logo and Corporate Website, Symbolizing Transformation of Company Culture to Meet the Changing Needs of Clients in the Life Science Community Today. 3AbbVie to Host Second-Quarter Earnings Conference Call 2AbbVie to Host Second-Quarter Earnings Conference Call 3AbbVie to Host Second-Quarter Earnings Conference Call 4AbbVie to Host Second-Quarter Earnings Conference Call 5AbbVie to Host Second-Quarter Earnings Conference Call 6
... , , New collaborative research program to study effects ... Dec. 30 A new research program called the Medication ... to study the effects of prescription medications used during pregnancy. ... Drug Administration and researchers at the HMO Research Network Center ...
... , BOSTON, Dec. 30 Solos Endoscopy, Inc. (Pink ... to a prosperous 2010, following a solid year in 2009, due ... the closing months of 2009, Solos Endoscopy, Inc. has taken the ... of surgical endoscopy instruments. This will allow the MammoView(TM) line to ...
Cached Medicine Technology:FDA, Health Organizations to Study Safety of Medications Taken During Pregnancy 2FDA, Health Organizations to Study Safety of Medications Taken During Pregnancy 3Solos Endoscopy, Inc. Set to Increase Business Through Sales and Product Development in 2010 2
(Date:7/23/2014)... if a suspicious skin lesion is painful or itchy ... to be cancerous, according to a new study headed ... Dermatology at Temple University School of Medicine. , The ... July 23, 2014, found that nearly 36. 9 percent ... 28.2 percent involve pain. Non-melanoma skin cancers specifically, ...
(Date:7/23/2014)... Celebrating a decade of philanthropy in 2014, The ... of $1,070,000 in grants to 20 New Jersey non-profit ... Foundation’s 1,000th grant. , “The Horizon Foundation for New ... community-based organizations that are working to improve public health ... State,” said Robert A. Marino, Horizon Blue Cross Blue ...
(Date:7/23/2014)... Inventor and entrepreneur Delegate Joe T. May will ... pump – sharing his passion for technology and innovation ... , With 24 patents granted and three pending, this ... the General Assembly since Thomas Jefferson. Inventions credited to ... seen on television, an instrument for measuring octane on ...
(Date:7/23/2014)... News) -- Regularly checking the pulse of a stroke ... "Screening pulse is the method of choice for checking ... have never had a stroke. Our study shows it ... to identify people who might need more thorough monitoring ... Bernd Kallmunzer, of Erlangen University in Germany. ...
(Date:7/23/2014)... in Shaanxi province, and the University of California, Davis, ... groundwork for establishing the Sino-U.S. Joint Research Center for ... held in the city of Yingchuan, China, during a ... Agriculture and China,s Ministry of Science and Technology. , ... and for our World Food Center and serves as ...
Breaking Medicine News(10 mins):Health News:Research led by Temple's chair of dermatology: Pain and itch may be signs of skin cancer 2Health News:The Horizon Foundation for New Jersey Awards More than $1 million in Grants to 20 Non-profit Organizations 2Health News:The Horizon Foundation for New Jersey Awards More than $1 million in Grants to 20 Non-profit Organizations 3Health News:The Horizon Foundation for New Jersey Awards More than $1 million in Grants to 20 Non-profit Organizations 4Health News:The Horizon Foundation for New Jersey Awards More than $1 million in Grants to 20 Non-profit Organizations 5Health News:Celebrating Innovation and Invention 2Health News:Routine Pulse Check May Prevent Second Stroke, Study Says 2Health News:Global food safety research agreement signed by China and UC Davis 2Health News:Global food safety research agreement signed by China and UC Davis 3
... learned from California reform debate to national group that ... WASHINGTON, Dec. 11 Two leading proponents of ... (CHW) President / CEO Lloyd Dean and Blue Shield ... founding members of Health CEOs for Health Reform (HC4HR), ...
... for successful freelance writer Lee Woodruff when her husband, Bob ... broadcasting from Iraq. Her experience as a caregiver and patient ... her keynote address at URAC,s Best Practices in Health Care ... in Orlando, Fla. , , ...
... dedicate funding source to public health , ... for Prevention today unveiled health reform recommendations to Congress ... to tackle the chronic diseases that are causing medical ... Under these proposals, federally funded insurance programs would ...
... WLP ), today,announced that associates nationwide pledged more ... in 2009. The WellPoint,Foundation, LLC, will match 50 percent ... million. , "Every ... health care system,and our health plans, members. The generosity ...
... Caesarean or induction should not be done before 39 weeks ... -- Late preterm birth puts newborns at increased risk for ... Petrini of the March of Dimes and colleagues studied ... babies born between 2000 and 2004. And they found that ...
... RALEIGH, N.C., Dec. 11 PRA International, a ... new office in,Mexico City, Mexico. With years ... market in 2005. The region,s existing base ... and infectious diseases,match favorably to PRA,s therapeutic focus. ...
Cached Medicine News:Health News:California Health Industry Leaders Help Launch National CEO Coalition for Health Reform 2Health News:California Health Industry Leaders Help Launch National CEO Coalition for Health Reform 3Health News:California Health Industry Leaders Help Launch National CEO Coalition for Health Reform 4Health News:California Health Industry Leaders Help Launch National CEO Coalition for Health Reform 5Health News:Best-selling Author Lee Woodruff, Futurist Ian Morrison to Speak at URAC's Best Practices Conference 2Health News:Best-selling Author Lee Woodruff, Futurist Ian Morrison to Speak at URAC's Best Practices Conference 3Health News:Partnership for Prevention Offers Health Reform Recommendations to Congress 2Health News:Partnership for Prevention Offers Health Reform Recommendations to Congress 3Health News:WellPoint Associates Pledge Record Amount to Community Organizations in 2009 2Health News:WellPoint Associates Pledge Record Amount to Community Organizations in 2009 3Health News:Late Preterm Birth Poses Developmental Risks 2Health News:PRA International Expands Operations in Mexico 2
... is pouncing on the T.L.I.F. market as the ... of CFRP clinical history and the amazing success ... Leopard is sure to be king of the ... from 7-18 mm in height. The footprint is ...
... provides anterior column support for single or ... to L5. The system consists of one ... that are stacked to a desired height, ... Fiber Reinforced Polymer material emulates the biomechanical ...
Anterior Interbody fusion with proven clinical performance. Large hole design. Request info fda status for sale....
... transmitted through sorted fiberglass bundles ... transmit it to a user's ... designed for rough, industrial handling ... low cost if they should ...
Medicine Products: